Doxycycline sensitivity of S. pneumoniae isolates [7]

Clinical Infectious Diseases

Volumn 36, Issue 8, 2003, Pages 1091-

  Lederman, E R ^a   Gleeson, T D ^b   Driscoll, T ^a   Wallace, Mark R ^a  

^a NAVAL MEDICAL CENTER SAN DIEGO   (United States)

^b WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXYCYCLINE; ANTIINFECTIVE AGENT;

ANTIBIOTIC THERAPY; BACTERIAL INFECTION; BACTERIUM ISOLATION; DRUG SENSITIVITY; LETTER; PENICILLIN RESISTANCE; PNEUMONIA; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE; DRUG EFFECT; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; NOTE;

ANTI-BACTERIAL AGENTS; DOXYCYCLINE; HUMANS; MICROBIAL SENSITIVITY TESTS; STREPTOCOCCUS PNEUMONIAE;

EID: 0037447027     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/374253     Document Type: Letter

References (3)

1. Johnson JR. Doxycycline for the treatment of community-acquired pneumonia. Clin Infect Dis 2002; 35:632.
2. Doern GV, Heilmann KP, Huynh HK, et al. Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999-2000, including a comparison of resistance rates since 1994-1995. Antimicrob Agents Chemother 2001; 45:1721-29.
3. Lonks JR, Garau J, Gomez L, et al. Failure of macrolide antibiotics treatment in patients with bacteremia due to erythromycin-resistant Streptococcus pneumoniae. Clin Infect Dis 2002; 35:556-64.